HCPCS Code J7633

Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram
Code effective Jan 01, 2007

HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J7633 is a valid 2026 HCPCS code meaning Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram or (Budesonide non-comp con) for short. HCPCS J7633 has been effective since 01/01/2007 and applies to Medical care.

HCPCS Code Details - J7633

HCPCS Level II Code
Section J - Drugs administered other than oral method, chemotherapy drugs
HCPCS Code J7633
Description

Long description:
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram

Short description:
Budesonide non-comp con

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code D1G - Drugs Administered through DME
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2007
Date added Added Jan 01, 2003

See also

  • HCPCS J7632 · Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams

  • HCPCS J7626 · Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg

  • HCPCS J7627 · Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg

  • HCPCS J7634 · Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.